Glycemic variability: Looking beyond the A1C

Diabetes Spectrum

Volumn 25, Issue 3, 2012, Pages 149-153

  Tylee, Tracy S ^a   Trence, Dace L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; CALCIUM; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; REPAGLINIDE;

ANHEDONIA; ANXIETY; AROUSAL; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL LINE; COHORT ANALYSIS; COMPUTER PROGRAM; CONCENTRATION LOSS; CONVENTIONAL INSULIN THERAPY; DAILY LIFE ACTIVITY; DATA ANALYSIS; DEPRESSION; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HEALTH INSURANCE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIVE INSULIN THERAPY; INTERMETHOD COMPARISON; INTERVENTION STUDY; META ANALYSIS (TOPIC); MOOD CHANGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PREVALENCE; PROLIFERATIVE RETINOPATHY; PSYCHOLOGICAL WELL BEING; RARE DISEASE; RISK FACTOR; RISK REDUCTION; SELF MONITORING; THINKING IMPAIRMENT; THORAX PAIN;

EID: 84865596787     PISSN: 10409165     EISSN: 19447353     Source Type: Journal    
DOI: 10.2337/diaspect.25.3.149     Document Type: Article

References (41)

1. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH: Glucose variability; does it matter? Endocr Rev 31:171-182, 2010
2. Kilpatrick ES: Arguments for and against the role of glucose variability in the development of diabetes complications. J Diabetes Sci Technol 3:649-655, 2009
3. Kilpatrick ES, Rigby AS, Atkin SL: For debate: glucose variability and diabetes complication risk: we need to know the answer. Diabet Med 27:868-871, 2010
4. Nalysnyk L, Hernandez-Medina M, Krishnarajah G: Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 12:288-298, 2010
5. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
6. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
7. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN, Group DER: Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial - revisited. Diabetes 57:995-1001, 2008
8. Monnier L, Colette C, Owens DR: Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2:1094-1100, 2008
9. Rodbard D: Glycemic variability: measurement and utility in clinical medicine and research - one viewpoint. Diabetes Technol Ther 13:1077-1080, 2011
10. Horvath EM, Benko R, Kiss L, Muranyi M, Pek T, Fekete K, Barany T, Somlai A, Csordas A, Szabo C: Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia 52:952-961, 2009
11. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687, 2006
12. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349-1354, 2008
13. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 51:183-190, 2008 (Pubitemid 50002199)
14. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29:1486-1490, 2006 (Pubitemid 44127568)
15. Service FJ, O'Brien PC: The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia 44:1215-1220, 2001 (Pubitemid 33010497)
16. Kilpatrick ES, Rigby AS, Atkin SL: Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 32:1901-1903, 2009
17. Kilpatrick ES, Rigby AS, Atkin SL: A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 31:2198-2202, 2008
18. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH: Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 52:2229-2232, 2009
19. Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ: The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 19:870-873, 2002 (Pubitemid 35177190)
20. Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P: Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 34:612-616, 2008
21. 1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 51:365-371, 2008
22. Gordin D, Ronnback M, Forsblom C, Makinen V, Saraheimo M, Groop PH: Glucose variability, blood pressure and arterial stiffness in type 1 diabetes. Diabetes Res Clin Pract 80:e4-e7, 2008
23. Snell-Bergeon JK, Roman R, Rodbard D, Garg S, Maahs DM, Schauer IE, Bergman BC, Kinney GL, Rewers M: Glycaemic variability is associated with coronary artery calcium in men with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study. Diabet Med 27:1436-1442, 2010
24. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C: Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes [article online]. Cardiovasc Diabetol 10:19, 2011. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056765/?tool= pubmed
25. Esposito K, Ciotola M, Carleo D, Schisano B, Sardelli L, Di Tommaso D, Misso L, Saccomanno F, Ceriello A, Giugliano D: Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 93:1345-1350, 2008 (Pubitemid 351519731)
26. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M: Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91:813-819, 2006 (Pubitemid 43357744)
27. Muggeo M, Verlato G, Bonora E, Ciani F, Moghetti P, Eastman R, Crepaldi G, de Marco R: Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study. Diabetologia 38:672-679, 1995
28. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R: Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 96:1750-1754, 1997 (Pubitemid 27400729)
29. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, Verlato G: Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 23:45-50, 2000 (Pubitemid 30022893)
30. Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM: Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. J Diabetes Complications 17:78-81, 2003 (Pubitemid 36279504)
31. Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y: The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. Diabetes Res Clin Pract 89:296-302, 2010
32. Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y: The effects of fasting plasma glucose variability and timedependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients. Diabetes Res Clin Pract 91:e40-e42, 2011
33. Zoppini G, Verlato G, Targher G, Casati S, Gusson E, Biasi V, Perrone F, Bonora E, Muggeo M: Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis 19:334-339, 2009
34. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M: Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10-16, 2004 (Pubitemid 38055587)
35. Esposito K, Giugliano D, Nappo F, Marfella R; Campanian Postprandial Hyperglycemia Study Group: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214-219, 2004 (Pubitemid 38924590)
36. Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ: Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 32:381-386, 2009
37. Hermanns N, Scheff C, Kulzer B, Weyers P, Pauli P, Kubiak T, Haak T: Association of glucose levels and glucose variability with mood in type 1 diabetic patients. Diabetologia 50:930-933, 2007 (Pubitemid 46559266)
38. Cox DJ, McCall A, Kovatchev B, Sarwat S, Ilag LL, Tan MH: Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes. Diabetes Care 30:2001-2002, 2007 (Pubitemid 47219408)
39. Niskanen L, Virkamaki A, Hansen JB, Saukkonen T: Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: evidence from the PREDICTIVE study. Diabetes Res Clin Pract 86:e15-e18, 2009
40. Kilpatrick ES, Rigby AS, Goode K, Atkin SL: Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 50:2553-2561, 2007 (Pubitemid 350060641)
41. Monnier L, Wojtusciszyn A, Colette C, Owens D: The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther 13:813-818, 2011